Study shows significant decline in prostate cancer diagnoses
the ONA take:
According to a new study published online in The Journal of Urology, researchers from Vanderbilt University Medical Center in Nashville, Tennessee, have found that new prostate cancer diagnoses in the United States dropped 28% in year following the United States Preventive Services Task Force (USPSTF) draft recommendation against routine prostate-specific antigen (PSA) screening for me.
For the study, researchers sought to assess the impact of the USPSTF's grade D recommendation in the year after the recommendation, which was announced in October 2011. Researchers used the National Cancer Database to identify new cancers diagnosed between January 2010 and December 2012.
Results showed that 12 months after the guidelines were published, new low-risk cancer diagnoses had decreased by 37.9%, new diagnoses of intermediate-risk disease dropped by 28.1%, and new diagnoses of high-risk prostate cancer decrease by 23.1%.
"The results raise concern that if this trend continues more men may be diagnosed at a point when their disease is advanced. Younger, healthier men with intermediate or high-risk disease would normally be candidates for aggressive local therapy and they may not be receiving a timely diagnosis under this policy," said first author Daniel Barocas, M.D., MPH, assistant professor of urological surgery and medicine.
Prostate cancer diagnoses in the United States dropped 28% in year following USPSTF draft recommendation.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|